Analgesic efficacy of opioids in chronic pain: Recent meta-analyses

British Journal of Pharmacology

Volumn 172, Issue 2, 2015, Pages 324-333

  Reinecke, H ^a   Weber, C ^a   Lange, K ^a   Simon, M ^a   Stein, C ^b   Sorgatz, H ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic pain; non cancer pain; non malignant pain; nonsteroidal anti inflammatory drugs; NSAID; opioids; physiotherapy; psychotherapy

Indexed keywords

CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENTANYL; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; OXYCODONE; OXYMORPHONE; PARACETAMOL; PLACEBO; TRAMADOL; ANALGESIC AGENT;

ARTHRITIS; CHRONIC PAIN; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; FIBROMYALGIA; HUMAN; INTENTION TO TREAT ANALYSIS; LOW BACK PAIN; META ANALYSIS; NEUROPATHIC PAIN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHYSICAL CAPACITY; PHYSIOTHERAPY; PSYCHODYNAMICS; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; REVIEW; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; SLEEP QUALITY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; SELECTION BIAS; TREATMENT OUTCOME;

ANALGESICS; CHRONIC PAIN; HUMANS; QUALITY OF LIFE; SELECTION BIAS; TREATMENT OUTCOME;

EID: 84920133062     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12634     Document Type: Review

References (62)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Allison PD, (2003). Missing data techniques for structural equation modeling. J Abnorm Psychol 112: 545-557.
4. Avouac J, Gossec L, Dougados M, (2007). Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 15: 957-965.
5. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. (2008). Opioid complications and side effects. Pain Physician 11 (2 Suppl): S105-S120.
6. Bjordal JM, Klovning A, Ljunggren AE, Slordal L, (2007). Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 11: 125-138.
7. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305: 1315-1321.
8. Bourgeois FT, Murthy S, Mandl KD, (2010). Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 153: 158-166.
9. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D, (2006). Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10: 287-333.
10. Chan AW, Altman DG, (2005). Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330: 753.
11. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC, (2013). Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev (8): CD004959.
12. Chou R, Carson S, (2008) Drug Class Review on Long-Acting Opioid Analgesics: Final Report Update 5. Oregon Health & Science University: Portland, OR.
13. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C, (2009a). Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 10: 147-159.
14. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. (2009b). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10: 113-130.
15. Dillie KS, Fleming MF, Mundt MP, French MT, (2008). Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med 21: 108-117.
16. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. (2009). Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 146: 238-244.
17. Edwards SJ, Clarke MJ, Wordsworth S, Borrill J, (2009). Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Int J Clin Pract 63: 841-854.
18. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM, (2001). Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-158.
19. Finnerup NB, Sindrup SH, Jensen TS, (2010). The evidence for pharmacological treatment of neuropathic pain. Pain 150: 573-581.
20. Frettlöh J, Maier C, Gockel H, Zenz M, Huppe M, (2009). [Characterization of chronic pain patients in German pain centers: core data from more than 10 000 patients]. Schmerz 23: 576-591.
21. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E, (2006). Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 174: 1589-1594.
22. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N, (2006). Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59: 7-10.
23. Gatti A, Mammucari M, Sabato E, Masucci L, Sabato AF, (2011). Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study. Adv Ther 28: 418-426.
24. Herr KA, Spratt K, Mobily PR, Richardson G, (2004). Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain 20: 207-219.
25. Hopewell S, McDonald S, Clarke M, Egger M, (2007). Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2): MR000010.
26. Idris NRN, Robertson C, (2009). The effects of imputing the missing standard deviations on the standard error of meta analysis estimates. Commun Stat Simul Comput 38: 513-526.
27. Iverson C, Christiansen S, Flanagin A, (2007) AMA Manual of Style: A Guide for Authors and Editors, 10th edn. Oxford University Press: New York, NY.
28. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. (2010). The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340: c365.
29. Management of Opioid Therapy for Chronic Pain Working Group (2010). VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.
30. Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, et al. (2007). Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146: 116-127.
31. McNicol ED, Midbari A, Eisenberg E, (2013). Opioids for neuropathic pain. Cochrane Database Syst Rev (8): CD006146.
32. Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, et al. (2011). Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res 63: 821-826.
33. Melnikova I, (2010). Pain market. Nat Rev Drug Discov 9: 589-590.
34. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269, W264.
35. Moore RA, Derry S, McQuay HJ, Straube S, Aldington D, Wiffen P, et al. (2010). Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain 149: 173-176.
36. National Opioid Use Guideline Group (2010). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain.
37. Noble M, Tregear SJ, Treadwell JR, Schoelles K, (2008). Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 35: 214-228.
38. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. (2010). Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev (1): CD006605.
39. Nuesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. (2010). Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 341: c3515.
40. Okie S, (2010). A flood of opioids, a rising tide of deaths. N Engl J Med 363: 1981-1985.
41. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. (2008). Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine 33: 90-94.
42. Papaleontiou M, Henderson CR Jr, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, et al. (2010). Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 58: 1353-1369.
43. Paulozzi L, Baldwin G, Franklin G, Kerlikowske RG, Jones CM, Ghiya N, et al. (2012). CDC grand rounds: prescription drug overdoses-a U.S. epidemic. MMWR Morb Mortal Wkly Rep 61: 10-13.
44. Pizzo PA, Clark NM, (2012). Alleviating suffering 101-pain relief in the United States. N Engl J Med 366: 197-199.
45. Prakash A, Risser RC, Mallinckrodt CH, (2008). The impact of analytic method on interpretation of outcomes in longitudinal clinical trials. Int J Clin Pract 62: 1147-1158.
46. SIGN (Scottish Intercollegiate Guidelines Network) (2011). Methodology checklist 1: systematic reviews and meta-analyses.
47. Solomon DH, (2010). Strategies for making analgesia safer: the role of comparative effectiveness research. Arthritis Rheum 62: 1568-1570.
48. Stauffer ME, Taylor SD, Watson DJ, Peloso PM, Morrison A, (2011). Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale. Int J Inflam 2011: 231926.
49. Stein C, (1997). Opioid treatment of chronic nonmalignant pain. Anesth Analg 84: 912-914.
50. Stein C, (2013). Opioids, sensory systems and chronic pain. Eur J Pharmacol 716: 179-187.
51. Stein C, Schäfer M, Machelska H, (2003). Attacking pain at its source: new perspectives on opioids. Nat Med 9: 1003-1008.
52. Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K, (2010). Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 149: 345-353.
53. Toblin RL, Mack KA, Perveen G, Paulozzi LJ, (2011). A population-based survey of chronic pain and its treatment with prescription drugs. Pain 152: 1249-1255.
54. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342: c7086.
55. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, et al. (2008). Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 11 (2 Suppl): S5-S62.
56. Turk DC, Wilson HD, Cahana A, (2011). Treatment of chronic non-cancer pain. Lancet 377: 2226-2235.
57. Von Korff M, Kolodny A, Deyo RA, Chou R, (2011). Long-term opioid therapy reconsidered. Ann Intern Med 155: 325-328.
58. Watson CP, Gilron I, Sawynok J, (2010). A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain. Pain Res Manag 15: 147-157.
59. Wells GA, Sultan SA, Chen L, Khan M, Coyle D, (2009) Canadian Agency for Drugs and Technologies in Health (ed.). Indirect Evidence: Indirect Treatment Comparisons in Meta-Analysis. CADTH: Ottawa.
60. Wissenschaftlicher Beirat Psychotherapie (2007). Methodenpapier: verfahrensregeln zur beurteilung der wissenschaftlichen anerkennung von methoden und verfahren der psychotherapie.
61. Woodcock J, (2009). A difficult balance-pain management, drug safety, and the FDA. N Engl J Med 361: 2105-2107.
62. Yates SL, Morley S, Eccleston C, de C Williams AC, (2005). A scale for rating the quality of psychological trials for pain. Pain 117: 314-325.